The landscape of dementia diagnosis has advanced radically with the appearance of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-based checks that could detect Alzheimer's pathology many years before signs or symptoms emerge. Though these technological advancements signify extraordinary progress in understanding neurodegenerative disorders, they've not... https://erini319hrz8.wikissl.com/user